Lepor H, Rigaud G
Department of Urology, Medical College of Wisconsin, Milwaukee.
J Urol. 1990 Mar;143(3):533-7. doi: 10.1016/s0022-5347(17)40012-7.
Transurethral resection of the prostate represents the operation most commonly performed by urologists in the United States. The objective of this study was to determine the efficacy of transurethral prostatectomy in men with moderate symptoms of prostatism. The efficacy parameters evaluated included peak urinary flow rate, obstructive and irritative symptom scores, and the global assessment by the patient of the voiding symptomatology. The mean peak urinary flow rate improved 108% after transurethral prostatectomy, and the mean obstructive and irritative symptom scores decreased 88 and 65%, respectively. The observed changes in urinary flow rates and symptom scores were statistically and clinically significant. Over-all, 84% of the patients indicated that the voiding symptoms were markedly improved after prostatic resection. Baseline urodynamic parameters were of no value for prediction of postoperative outcome. Several investigators recently reported their clinical experience with various pharmacological approaches for the treatment of symptomatic benign prostatic hyperplasia. Over-all, the degree of improvement in urinary flow rates and symptom scores achieved after transurethral prostatectomy exceeds all other therapeutic options that presently are available for the treatment of benign prostatic hyperplasia.
经尿道前列腺切除术是美国泌尿外科医生最常进行的手术。本研究的目的是确定经尿道前列腺切除术对有中度前列腺增生症状男性的疗效。评估的疗效参数包括最大尿流率、梗阻性和刺激性症状评分,以及患者对排尿症状的总体评估。经尿道前列腺切除术后,平均最大尿流率提高了108%,平均梗阻性和刺激性症状评分分别降低了88%和65%。观察到的尿流率和症状评分变化在统计学和临床上均具有显著意义。总体而言,84%的患者表示前列腺切除术后排尿症状明显改善。基线尿动力学参数对预测术后结果没有价值。几位研究人员最近报告了他们采用各种药物治疗有症状良性前列腺增生的临床经验。总体而言,经尿道前列腺切除术后在尿流率和症状评分方面取得的改善程度超过了目前可用于治疗良性前列腺增生的所有其他治疗选择。